Triumph Capital Management’s FT Vest US Equity Moderate Buffer ETF February GFEB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$170K Hold
3,871
0.03% 384
2026
Q1
$159K Sell
3,871
-15,724
-80% -$656K 0.03% 372
2025
Q4
$814K Buy
19,595
+2,183
+13% +$89.4K 0.18% 121
2025
Q3
$706K Buy
17,412
+1,706
+11% +$67.9K 0.19% 120
2025
Q2
$612K Sell
15,706
-6,753
-30% -$251K 0.18% 135
2025
Q1
$826K Buy
22,459
+9,161
+69% +$343K 0.28% 92
2024
Q4
$497K Sell
13,298
-1,086
-8% -$40.2K 0.17% 152
2024
Q3
$525K Buy
14,384
+56
+0.4% +$2K 0.19% 133
2024
Q2
$508K Sell
14,328
-11,753
-45% -$406K 0.2% 120
2024
Q1
$896K Buy
+26,081
New +$877K 0.37% 61

Other funds holding GFEB

Triumph Capital Management's GFEB Position: Q2 2026 in Review

Triumph Capital Management held its FT Vest US Equity Moderate Buffer ETF February (GFEB) position steady in Q2 2026 at 3,871 shares worth $170K. The position accounts for 0.03% of the portfolio, ranked #384.

Triumph Capital Management first reported a position in GFEB in Q1 2024 and has held it in 10 quarters since. The position peaked at $896K in Q1 2024. 117 funds tracked by Wall St. Rank hold GFEB as of Q2 2026.

  • Triumph Capital Management held 3,871 shares of FT Vest US Equity Moderate Buffer ETF February worth $170K as of Q2 2026.
  • Triumph Capital Management left its FT Vest US Equity Moderate Buffer ETF February share count unchanged in Q2 2026.
  • FT Vest US Equity Moderate Buffer ETF February made up 0.03% of Triumph Capital Management's portfolio in Q2 2026, its #384 holding.
  • Triumph Capital Management first reported a position in FT Vest US Equity Moderate Buffer ETF February in Q1 2024 and has held it in 10 quarters since.
  • Triumph Capital Management's FT Vest US Equity Moderate Buffer ETF February position peaked at $896K in Q1 2024.
  • 117 funds tracked by Wall St. Rank held FT Vest US Equity Moderate Buffer ETF February as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.